Jane Street Group, LLC Neu Base Therapeutics, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.17 - $0.39 $1,757 - $4,031	10,336 New	10,336 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.41 - $1.3 $5,803 - $18,402	14,156 New	14,156 $6,000
Q2 2020 Aug 17, 2020	SELL	$6.69 - $11.51 $113,776 - $195,750	-17,007 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.77 - $8.23 $81,123 - $139,967	17,007 New	17,007 $121,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.